WATSON 843 (Bisoprolol fumarate and hydrochlorothiazide 10 mg / 6.25 mg)
Pill imprint WATSON 843 has been identified as Bisoprolol fumarate and hydrochlorothiazide 10 mg / 6.25 mg.
Bisoprolol/hydrochlorothiazide is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. Risk cannot be ruled out during pregnancy. Bisoprolol/hydrochlorothiazide 10 mg / 6.25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 843 (Bisoprolol fumarate and hydrochlorothiazide 10 mg / 6.25 mg)
- 10 mg / 6.25 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide colloidal
dibasic calcium phosphate
|NDC Code||Manufacturer / Repackager|
|23490-6503||Palmetto State Pharmaceuticals Inc (repackager)|
|66336-0612||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
Bisoprolol fumarate and hydrochlorothiazide is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...